chronic

Diabetes Insipidus (Central)

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources2 sources

Endocrine Society Clinical Practice Guidelines · Egyptian National Drug Formulary, endocrine 2024, desmopressin acetate monograph, cranial diabetes insipidus (printed p. 242)

Verified against2 documents

Egyptian National Drug Formulary, endocrine 2024, desmopressin acetate monograph, cranial diabetes insipidus (printed p. 242)
Arginine Vasopressin Disorder (Diabetes Insipidus) - disease-level clinical article (diabetes-insipidus-referral-clinical.txt)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (6)

Excess thirst, excess urination, and waking at night to void are shared by both central and nephrogenic forms; urine output exceeds 3 L a day in adults [excess thirst]
Waking to urinate is often the earliest clue to mild concentrating trouble, though it is a nonspecific complaint on its own
In a child the picture can be vague, with severe dehydration, constipation, vomiting, fever, irritability, poor growth, or failure to thrive [constipation · dehydration · failure to thrive · fever · irritability · vomiting]
A child with a brain tumor may add headaches and visual disturbance on top of the usual thirst and urination symptoms
The central form can also bring weakness, tiredness, low energy, and muscle aches [fatigue · muscle pain]
The central form has been linked to lower bone density in the lower spine and hip, for reasons not fully understood

Tests (12)

Polyuria is defined by weight-based volume thresholds that fall with age, from over 150 mL per kg a day at birth down to over 50 mL per kg a day in older children and adults
Dilute urine is defined as an osmolality under 300 with a serum sodium that is normal or high
A urine osmolality above 800 shows the kidney is responding normally to hormone and rules out the central form
A high serum sodium above 146 points toward the central or kidney-resistant form, while a low-normal or low sodium under 135 points toward drinking too much water
A high plasma osmolality of 300 or more is typical of the central or kidney-resistant form, while a normal or low level of 280 or less points to excess drinking
During fluid restriction, the urine stays dilute instead of concentrating properly in both the central and kidney-resistant forms
After water restriction, desmopressin raises urine concentration by over 100 percent in complete central disease and up to 50 percent in the partial form
In the kidney-resistant form, desmopressin barely raises urine concentration in the partial type and not at all in the complete type
The central form is confirmed by high plasma concentration together with dilute urine and a urine output above 4 to 5 mL per kg per hour for two hours running after surgery
Copeptin, a more stable stand-in for the hormone itself, tracks closely with true hormone levels across a wide range of concentrations
Infusing concentrated saline while measuring copeptin is now favored by many specialists over the older fluid-restriction test
A gadolinium-enhanced MRI of the pituitary region looks for structural causes such as a tumor, an empty sella, or infiltrative disease

If not this — what else fits (10)

Drinking too much water on its own, apart from any hormone problem, causes polyuria
Sugar spilling into the urine in poorly controlled diabetes mellitus causes polyuria
A high-protein diet driving urea excretion can cause polyuria
Receiving a lot of IV sugar-water solution or other fluids can itself produce high urine output
Breakdown of body tissue generating urea can drive polyuria
Mannitol use is a recognized cause of polyuria
Irritable bladder syndrome is on the differential for urinary frequency
Nocturia can simply reflect drinking fluids close to bedtime
In men, an enlarged prostate is a common cause of nighttime urination
Diabetes mellitus itself is a common cause of nighttime urination

SourceStatPearls "Arginine Vasopressin Disorder (Diabetes Insipidus)" - disease-level clinical article

Presentation findings are traced to the source above.

DESMOPRESSIN ACETATE

1st line

Strength0.1 mg

Formoral.solid

Adult dose and duration

Initially 0.1 mg three times daily; total daily oral dose normally lies in the range of 0.2 to 1.2 mg (usual maintenance 0.1 mg to 0.2 mg three times daily) - long-term

Paediatric dose

Specialist pediatric endocrinology titration only

Dose source

Egyptian National Drug Formulary, endocrine 2024, desmopressin acetate monograph, cranial diabetes insipidus (printed p. 242)

Why

Synthetic vasopressin analogue that replaces the antidiuretic hormone deficient in central diabetes insipidus, reducing excessive urine output by increasing water reabsorption in the kidney; ineffective in nephrogenic DI, where the kidney cannot respond to the hormone at all.

Cautions

There is a risk of severe hyponatremia and water intoxication; monitor fluid intake and serum sodium regularly.
Instruct patient to drink only when thirsty.
The formulary's maintenance is 0.1-0.2 mg three times daily, with a total daily range up to 1.2 mg - the dose here stops at 0.8 mg, which is the more cautious end, not the label's ceiling.
Desmopressin is effective ONLY in central DI and is ineffective in nephrogenic DI.

Egyptian brands

Egyptian brand	Manufacturer	Indicative price
DESMODJUST 0.1 MG 30 TABS.	MARCYRL PHARMACEUTICAL INDUSTRIES (MPI)	210.00 EGP (7.00/unit)
OMEGAPRESS 0.1 MG 30 TABS.	ATCO PHARMA > OMEGA PHARMA OPCI	288.00 EGP (9.60/unit)

REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)

1st line

Dose source

Arginine Vasopressin Disorder (Diabetes Insipidus) - disease-level clinical article (diabetes-insipidus-referral-clinical.txt)

Why

Carries the referral criteria and warning signs for this condition, which apply whichever treatment is chosen.

Cautions

RED FLAG - Monitor for hyponatremia and educate on the warning signs of water intoxication and hyponatremia (nausea, vomiting, lethargy, headache, confusion, seizures, coma).

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.